ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø

ÀÇ·áÁø »çÁø
±è¹ÎÇü ±³¼ö
Áø·á°ú °¨¿°³»°ú HOME

Àü¹®Áø·áºÐ¾ß


¹ß¿­Áúȯ, °¨¿°Áúȯ, ºÒ¸í¿­, ÆÐÇ÷Áõ, ¿¡ÀÌÁî, ´ÙÁ¦³»¼º¼¼±Õ°¨¿°, ¿©ÇàÀÚ °¨¿°, ¼ºÀο¹¹æÁ¢Á¾
¡Ø ¿Ü·¡ ½Ã°£ ¿Ü ÁÖ20½Ã°£ ¿ø³» °¨¿°°ü¸®¾÷¹«

ÀüÈ­ ¿¹¾à 1522-2500

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2024-07-22 ~ 2024-07-27)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¿Ü·¡Áø·á¿Ü·¡Áø·á
¿ÀÈÄ ¿Ü·¡Áø·á¿Ü·¡Áø·á

ÇзÂ

ÇзÂ

¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ Çлç

¿¬¼¼´ëÇб³ ´ëÇпø ÀÇÇдëÇпø ¹Ú»ç

¿¬¼¼´ëÇб³ ´ëÇпø ÀÇÇдëÇпø ¼®»ç

°æ·Â

°æ·Â

2009 ~ 2013¿¬¼¼´ëÇб³ ½ÅÃ̼¼ºê¶õ½ºº´¿ø ³»°ú Àü°øÀÇ

2013 ~ 2014¿¬¼¼´ëÇб³ ½ÅÃ̼¼ºê¶õ½ºº´¿ø °¨¿°³»°ú ÀÓ»ó °­»ç

2014 ~ 2021ºÐ´çÁ¦»ý º´¿ø °¨¿°°ü¸® ½ÇÀå

2021 ~ 2023¿¬¼¼´ëÇб³ ¿ëÀμ¼ºê¶õ½ºº´¿ø Áø·á±³¼ö

~ 2023ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø ÀÓ»óºÎ±³¼ö

2024 ~ ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø ºÎ±³¼ö

ÇÐȸȰµ¿

ÇÐȸȰµ¿

´ëÇѳ»°úÇÐȸ ȸ¿ø

´ëÇÑÈ­Çпä¹ýÇÐȸ Á¤È¸¿ø

´ëÇÑ°¨¿°ÇÐȸ Á¤È¸¿ø

³í¹®/Àú¼­

³í¹®/Àú¼­
´ëÇ¥ ³í¹® ¹× Àú¼­
1. AI ÈäºÎ¹æ»ç¼± °Ë»çÀÇ COVID-19 ȯÀÚ ½ºÅ×·ÎÀÌµå ¹ÝÀÀ ¿©ºÎ ºÐ¼®/ Novel risks of unfavorable corticosteroid response in patients with mild-to-moderate COVID-19 identified by artificial intelligence-assisted analysis of chest radiographs (JCM, 2023.9)

2. AI ÈäºÎ¹æ»ç¼± °Ë»çÀÇ COVID-19 ȯÀÚ ¿¹ÈÄ ºÐ¼®¿¡ ¹ÌÄ¡´Â ¿µÇâ/ Clinical Implication and Prognostic Value of Artificial-Intelligence-Based Results of Chest Radiographs for Assessing Clinical Outcomes of COVID-19 Patients (Diagnostics,2023.6)

3. ¹é½ÅÀû¿ëÀÌ SARS-CoV-2 ÇϺκ¯ÀÌ ÀüÆÄ¿¡ ¹ÌÄ¡´Â ¿µÇ⠺м®/ Vaccine Effect on Household Transmission of Omicron and Delta SARS-CoV-2 Variants (JKMS,2023.1)

4. ¹«Áõ»ó¼¼±Õ´¢¿¡¼­ Ç×»ýÁ¦ »ç¿ë ½Çźм®/ Appropriateness of antibiotics use for patients with asymptomatic bacteriuria or urinary tract infection: A retrospective observational multicenter study in Korea (OFID,2022.12)

5. SARS-CoV-2ÀÇ º´¿ø³» 2Â÷ ÀüÆÄ¿¡ ÀÖ¾îRTLS ÀÇ À¯¿ë¼º / The Potential Role of an Adjunctive Real-Time Locating Systemin Preventing Secondary Transmission of SARS-CoV-2 in a Hospital Environment: Retrospective Case-Control (JMIR, 2022.10)

6. COVID-19 ÀÇ Áúº´ °æ°ú¿¡ ÀÖ¾î Ç×ü°¡°¡ ¹ÌÄ¡´Â ¿µÇâ / Antibody Level Predicts the Clinical Course of Breakthrough Infection of COVID-19 Caused by Delta and Omicron Variants: A Prospective Cross-Sectional Study (OFID, 2022.5)

7. À§¸·¼º´ëÀå¿°ÀÇ Ä¡·á ÇàÅ Á¶»ç/ Description of antibiotic treatment in adults tested for Clostridioides difficile infection:a single-center case–control study (BMC infectious diseases, 2022.1)
8. VISA ¿ø³» ¹ß»ýÀÇ °íÂû/ Lessons Learned from an Experience with Vancomycin-Intermediate Staphylococcus aureus Outbreak in a Newly Built Secondary Hospital in Korea (Pathogens, 2021.5)

9. COVID-19 vaccine Á¢Á¾¿¡ º´¿ø³» Ä·ÆäÀÎÀÌ ¹ÌÄ¡´Â ¿µÇâ/ Effect of a hospital-wide campaign on COVID-19 vaccination uptake among healthcare workers in the context of raised concerns for life-threatening side effects (PLOS ONE, 2021.10)

10. ÀüÀå À¯Àüü ºÐ¼®À» ÅëÇÑ ´ëÁ¦ ³»¼º Acinetobacter baumannii ÀÇ ÀÓ»óÀû Ư¼º ÀÌÇØ/ Using comparative genomics to understand molecular features of carbapenem-resistant Acinetobacter baumannii from South Korea causing invasive infections and their clinical implications (PLOS ONE,2020)

Àú¼­/Àú¼ú
Á¾¼³: ¸¸¼º Äڷγª19 ÁõÈıºÀÇ Æ¯¼º ¹× ¼ö¼ú ½Ã À¯ÀÇÁ¡/ Surgery preparation for the patients with Long COVID (´ëÇѼö¼ú°¨¿°ÇÐȸ, 2023.2)

¾ð·Ðº¸µµ